TP53 and melanoma: In this study, we find that on targeting the DNA‐binding domain of X. tropicalis P53, about 19% of homozygous mutants developed nevi and melanomas, which provides a valuable model for both the investigation of phenotypic heterogeneity predisposed by germline TP53 alterations and the mechanistic study of P53 network‐mediated melanoma development.